Home » Author Archive

Image for EBR Systems, Inc. (ASX:EBR) Insider Allan Will Buys 110,000 Shares

EBR Systems, Inc. (ASX:EBR) Insider Allan Will Buys 110,000 Shares

EBR Systems, Inc. (ASX:EBR – Get Free Report) insider Allan Will bought 110,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The shares were bought at an average price of A$0.14... More of this article »
Image for Oxbridge Re Holdings Reports Potential Underwriting Losses in Connection with Hurricanes Helene and Milton

Oxbridge Re Holdings Reports Potential Underwriting Losses in Connection with Hurricanes Helene and Milton

Oxbridge Re Holdings Limited (NASDAQ: OXBR) recently disclosed potential underwriting losses in a Current Report on Form 8-K. The losses are reportedly associated with Hurricanes Helene and Milton, which made landfall in Florida in... More of this article »
Image for **GlucoTrack (NASDAQ: GCTK) Approves Increase in Authorized Shares**WASHINGTON, D.C. 20549 – GlucoTrack, Inc. (NASDAQ: GCTK) reported on January 3, 2025, that they held a Special Meeting of its stockholders in which they approved an amendment to the

**GlucoTrack (NASDAQ: GCTK) Approves Increase in Authorized Shares**WASHINGTON, D.C. 20549 – GlucoTrack, Inc. (NASDAQ: GCTK) reported on January 3, 2025, that they held a Special Meeting of its stockholders in which they approved an amendment to the

** This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read GlucoTrack’s 8K filing here. GlucoTrack Company Profile (Get Free Report) GlucoTrack,... More of this article »
Image for Blaine Davis Sells 4,028 Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Stock

Blaine Davis Sells 4,028 Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Stock

Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Get Free Report) CFO Blaine Davis sold 4,028 shares of the stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $16.83, for a total transaction... More of this article »
Image for Minerva Neurosciences (NASDAQ:NERV) Now Covered by StockNews.com

Minerva Neurosciences (NASDAQ:NERV) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) in a research note released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately,... More of this article »